Daily Stock Analysis, BIO, Bio Rad Laboratories Inc, priceseries

Bio Rad Laboratories Inc. Daily Stock Analysis
Stock Information
Open
222.67
Close
222.96
High
224.43
Low
221.78
Previous Close
223.11
Daily Price Gain
-0.15
YTD High
242.79
YTD High Date
Aug 3, 2017
YTD Low
181.87
YTD Low Date
Jan 3, 2017
YTD Price Change
40.05
YTD Gain
21.90%
52 Week High
242.79
52 Week High Date
Aug 3, 2017
52 Week Low
154.89
52 Week Low Date
Nov 1, 2016
52 Week Price Change
61.57
52 Week Gain
38.15%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 27. 2015
127.18
Mar 26. 2015
134.99
19 Trading Days
6.14%
Link
LONG
Feb 16. 2016
127.36
Mar 8. 2016
135.00
15 Trading Days
6.00%
Link
LONG
Apr 17. 2017
203.87
May 17. 2017
220.74
22 Trading Days
8.27%
Link
Company Information
Stock Symbol
BIO
Exchange
NYSE
Company URL
http://www.bio-rad.com
Company Phone
5107247000
CEO
Norman D. Schwartz
Headquarters
California
Business Address
1000 ALFRED NOBEL DRIVE, HERCULES, CA 94547
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0000012208
About

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Description

Bio-Rad Laboratories, Inc. manufactures and supplies products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and software which address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. It operates in Europe, Pacific Rim, the United States, and internationally. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.